Table 3 Hazard ratio and 95% CI for age IPSS-R and the flow variables used in the models.

From: A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes

  B*** HR (95% CI) p
Age 0.024 1.024 (1.009–1.039) 0.002
IPSS-R 0.687 1.988 (1.583–2.497)  < 0.0001
% total monocytes 0.039 1.040 (0.992–1.090) 0.106
% classical monocytes** –1.940 0.144 (0.032–0.645) 0.011
% CD16+ monocytes* 0.345 1.425 (1.192–1.702)  < 0.0001
% CD16+ monocytes** 1.944 6.98 (1.558–31.343) 0.011
Number of abnormal antigen expressions in monocytes 0.359 1.432 (1.142–1.795) 0.002
% CD34 + myeloid progenitors 0.156 1.169 (1.100–1.241)  < 0.0001
Number of abnormal antigen expressions in myeloid progenitors 0.237 1.289 (1.075–1.546) 0.006
% H1 –7.068 0.001 (0.00–0.039)  < 0.0001
  1. *Among all nucleated cells; **among all monocytes; ***B = cumulative regression coefficient.